Literature DB >> 26227224

A case of massive hemoptysis related to a smoking-history: an acquired form of the Dieulafoy's disease?

A Padilla-Serrano1, V Estrella-Palomares2, B Martínez-Palacios2, J González-Spínola3.   

Abstract

The hypervascularization of the bronquial wall, secondary to chronic bronchopulmonary inflammation is a bleeding etiology in smokers, but insufficient to explain certain massive recurrent cases. We report a case of a woman with a smoking history who presented a recurrent and massive hemoptysis. A diagnostic study with laboratory tests, bronchoscopy, computed tomography and echocardiogram did not identify the etiological cause. However, bronchial arteriography showed right and left bronchial tortuous and dilated arteries and demonstrated that a bronchovascular fistula was the origin of the hemoptysis. An acquired form of the Dieulafoy's disease in this context of a smoking history might justify such findings. Bronchial arteriography as a diagnostic method should be the preferred choice rather than bronchoscopy in these cases.
Copyright © 2015 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Bronchovascular fistula; Dieulafoy's disease; Hypervascularization; Massive hemoptysis; Smoking history; Vascular lesion

Mesh:

Year:  2015        PMID: 26227224     DOI: 10.1016/j.rppnen.2015.06.010

Source DB:  PubMed          Journal:  Rev Port Pneumol (2006)        ISSN: 0873-2159


  3 in total

1.  Two cases of Dieulafoy lesions of the bronchus with novel comorbid associations and endobronchial ablative management.

Authors:  Hardik S Sheth; Fabien Maldonado; Robert J Lentz
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

2.  Clinical characteristics and treatments for bronchial Dieulafoy's disease.

Authors:  Wenfang Chen; Pingping Chen; Xiuyu Li; Xinglin Gao; Jing Li
Journal:  Respir Med Case Rep       Date:  2019-01-07

Review 3.  Research advances in Dieulafoy's disease of the bronchus (Review).

Authors:  Xiqian Xing; Jie Liu; Shuanglan Xu; Yishu Deng; Jiao Yang
Journal:  Exp Ther Med       Date:  2021-12-01       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.